laboratori corp america hldg
labcorp file februari day last year
comprehens review file make follow observ
februari labcorp million share outstand
y/i lower compani averag basic share count labcorp
disclos addit detail chiltern paml acquisit chiltern contribut
million revenu septemb
impli covanc grew organ paml compani intend
acquir membership interest two jv member labcorp
provid updat progress leverag combin strength lcd
cdd labcorp provid detail acquisit chiltern close
septemb labcorp includ commentari launchpad covanc
labcorp provid updat pama fda regul ldt
compani revenu gener unit state labcorp expand
footprint acquisit central bill fell modestli
percentag lcd revenu lcd revenu medicar
medicaid program labcorp own leas number primari oper
facil throughout us uk germani belgium china india singapor
laboratori facil covanc phase research unit dalla tx accredit
cap labcorp full-tim equival employe world-wide labcorp
provid updat long-term debt oblig follow acquisit
covanc labcorp reinstat share repurchas program purchas
million share labcorp pension unfund statu
million smaller million bad debt expens
million repres lab revenu y/i
labcorp lengthi list outstand labcorp list nine new
account pronounc includ detail expect impact
ceo david king cfo glenn eisenberg provid necessari certif
februari pricewaterhousecoop provid unqualifi opinion
disclosur
lh quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
barclay laboratori corp america hldg
laboratori corp america hldg lh
overweight labcorp remark track
record execut led lead organ
growth augment value-enhanc
acquisit covanc acquisit continu
theme expect expertis
organ posit labcorp premier
partner choic companion diagnost play
greater role clinic decis make
labcorp integr strategi covanc yield
higher sustain growth profil compani
addit lab industri consolid lead
acceelr revenu ep growth upsid
case reflect upsid ep
reimburs headwind congression
action oner clinic lab
hospit begin greater penetr esoter test
volum downsid case reflect
downsid ebitda billion
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
barclay laboratori corp america hldg
labcorp file februari day last year
comprehens review file make follow observ
februari labcorp million share outstand
y/i lower compani averag basic share count
labcorp disclos addit detail chiltern paml acquisit chiltern
contribut million revenu septemb
impli covanc grew organ paml compani intend
acquir membership interest two jv member result
acquisit paml labcorp acquir paml ownership interest six jv
consolid evalu consolid acquir
membership interest evalu time
labcorp provid updat progress leverag combin strength
lcd cdd detail strength pleas see report februari
deliv global life scienc strategi
full thought
report
laboratori corp america
check cro box
labcorp provid detail acquisit chiltern close
septemb chiltern contract research organ cro known
relationship small mid-size biopharma compani expertis oncolog
labcorp paid million all-cash deal financ combin
bank financ bond chiltern includ compani covanc drug
develop cdd segment chiltern achiev revenu million
chiltern contribut million revenu million oper
labcorp includ commentari launchpad covanc april labcorp
announc expand launchpad busi process improv initi
includ cdd segment labcorp gener save expect
achiev addit net save three-year period end
initi expect align peopl capabl client busi demand
util autom new inform technolog platform creat effici
enhanc custom experi cdd invest commerci
oper process throughout compani record million
restructur charg million lcd million cdd
labcorp provid updat pama fda regul ldt
pama labcorp includ view protect access medicar act
pama file includ expect reduct
million clf rev labcorp dx revenu total compani
note believ fail properli includ market data larg portion
laboratori industri calcul preliminari rate labcorp
believ new clf affect lcd revenu inclus
payor impact clf
ldt labcorp note fda issu draft guidanc oversight lab
develop test ldt report publish decemb said
outcom ultim impact propos difficult predict time
novemb fda announc would releas final guidanc
moment instead agenc said would continu collabor stakehold
new administr congress determin right approach januari
fda releas discuss paper outlin potenti risk-bas approach
barclay laboratori corp america hldg
regul ldt labcorp believ impact propos
busi difficult predict time
compani revenu gener unit state
compani lab revenu unit state versu within covanc
labcorp expand footprint acquisit central bill
fell modestli percentag lcd revenu labcorp primari lab
compani also approxim patient servic center
y/i addit compani in-offic phlebotomist labcorp central
bill declin revenu consolid compani
believ result acquisit made throughout year
lcd revenu medicar medicaid program
compar respect compani note
lcd revenu gener clinic lab fee schedul
clf medicar physician fee schedul respect impli medicaid
program repres lcd revenu approxim
respect labcorp diagnost revenu gener
labcorp own leas number primari oper facil throughout
us uk germani belgium china india singapor switzerland legaci labcorp
facil primarili locat covanc intern
unit servic bill bill contract barclay laboratori corp america hldg
believ compani primari facil addit result paml
chiltern acquisit lcd new site two lab spokan washington
facil covanc phase research unit dalla tx accredit cap
addit compani lortan va laboratori accredit ascld
disciplin biolog categori nuclear dna mitochondri dna bodi fluid
character individu characterist databas test compani full servic
forens facil uk accredit iso/iec uk accredit
labcorp diagnost divisioncov drug developmentcitystateown/leasecitystateown/leasebirminghamalleasedmechelenbelgiumleasedphoenixazownedbeij angelescaleasedbangaloreindia leasedmonroviacaleasedsingaporeleasedsan diegocaleasedharrogateunit kingdomownedsan franciscocaleasedle unit kingdomownedtustincaleasedmaidenheadunit kingdomleasedenglewoodcoleasedsloughunit kingdomleasedsheltonctleasedsan franciscocaliforniahollywooodflleasedindianapolisindianaleasedtampaflleasedgreenfieldindianaownedtuckergaleasedgaithersburgmarylandleasedchicagoilleasedcranford new jerseyleaseditascailleasedprinceton new jerseyleasedlenexaksleasedwest trentonnew jerseyleasedlouisvillekyleasedcarynorth carolinaleasedlafayettelaleaseddenverpennsylvaniaownedwestboroughmaleasedalicetexasownedbattl creekmiownedchantillyvirginaleasedrosevillemnleasedcumberlandvirginaownedst paulmnownedgenevaswitzerlandleasedkansa citi moownedmadison wisconsinownedewingnjleasedraritannjownednew lcd fenmownedspokan yorknyleasedburlington triangl park cityokleasedbrentwoodtnleasedknoxvilletnleasedaustintxleaseddallastxleasedhoustontxleasedsan antoniotxleasedchesapeakevaleasedherndonvaleasedlortonvaleasedseattlewaleasedspokan kingdomleas barclay laboratori corp america hldg
servic mani area forens analysi chart list labcorp lab
 five lab intern iso accredit
labcorp full-tim equival employe world-wide employe
product obfusc due chiltern acquisit subsidiari
 four collect bargain agreement cover approxim employe
non-u base subsidiari collect bargain agreement cover
approxim employe sinc revenu per employe product
measur improv time period ebitda per employe
declin cffo per employe declin
import note chiltern like headwind metric
compani employe includ partial year month result
includ
namelocationdatelabcorp diagnost divisionlabcorp region test facilityraritan region test facilityknoxvil region test facilitysan antonio coagulationdenv gamma facilitylav region test facilitydublin sciencescalabasa region test facilitydalla region test facilitydenv geneticssanta fe new geneticswestborough gamma facilitymontr region test facilityphoenix region test facilitybirmingham oncologybrentwood molecular biolog patholog cmbp research triangl park region test facilitytampa oncologyphoenix drug developmentcov central laboratori servicesindianapoli covanc central laboratorytokyo research developmentshanghai asia central laboratori servicesgeneva barclay laboratori corp america hldg
labcorp provid updat long-term debt oblig
credit facil septemb labcorp enter new term
loan term loan facil matur septemb term
loan balanc decemb decemb financ
acquisit covanc compani enter billion term loan
matur five year close acquisit term loan balanc
decemb decemb compani
borrow outstand revolv credit facil compani term
loan facil revolv credit facil labcorp subject neg coven
limit subsidiari indebted certain coven typic invest
grade-r borrow compani requir maintain certain leverag ratio
labcorp complianc coven term loan facil new
revolv credit facil decemb decemb
effect interest rate revolv credit facil effect
interest rate term loan term loan
zero-coupon convert subordin note labcorp million aggreg
princip amount zero-coupon bond due decemb
one thousand dollar princip amount matur note convert
share compani common stock subject adjust certain
circumst one follow condit occur sale price
compani common stock least trade day period consecut
trade day end last trade day preced quarter reach specifi
threshold begin declin per quarter reach
approxim quarter begin juli accret convers
price per share common stock last day preced quarter accret
convers price per share equal issu price note plu accru origin
issu discount accru conting addit princip divid number
share common stock issuabl upon convers note day
convers trigger price fourth quarter credit rate
assign note ps rate servic bb- note
call redempt specifi corpor transact occur
debt secur consist aggreg princip amount
senior note due aggreg princip amount senior
pery/yebitda pery/ycffo barclay laboratori corp america hldg
note due interest note payabl semi-annu march
septemb year commenc march net proce
offer note deduct underwrit discount
expens offer net proce use pay senior note
due august well portion cash consider fee
expens connect chiltern acquisit
septemb compani announc success competit
consent solicit convert senior note due total
million assum part acquisit sequenom octob
compani retir million outstand note
januari labcorp issu senior note repres
debt secur consist aggreg princip amount senior note
due aggreg princip amount senior note due
aggreg princip amount senior note due
aggreg princip amount senior note due interest note
payabl semi-annu februari august year commenc
august net proce use pay portion cash consider
fee expens connect covanc acquisit
novemb labcorp issu new senior note pursuant
compani effect shelf registr senior note consist
aggreg princip amount senior note due aggreg
princip amount senior note due interest note payabl
semi-annu novemb may year commenc may
net proce use repay outstand borrow
compani revolv credit facil gener corpor purpos
labcorp enter two fixed-to-vari interest rate swap agreement
senior note due aggreg notion amount
variabl interest rate base one-month libor plu hedg
chang fair valu portion compani long term debt deriv
financi instrument account fair valu hedg senior note due
outstand time interest rate swap includ long
term asset liabil applic ad valu senior note
aggreg fair valu million decemb
barclay laboratori corp america hldg
follow acquisit covanc labcorp reinstat share
repurchas program purchas million share compani
million remain current share repurchas author
senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due long-term barclay laboratori corp america hldg
quarterperiodsharesavg pricetot repurchasedmax amount programstot total total total total barclay laboratori corp america hldg
labcorp pension unfund statu million smaller
million labcorp defin benefit retir plan nonqualifi
supplement retir plan plan close new particip sinc
decemb employe particip compani plan longer
earn service-bas credit continu earn interest credit
effect januari employe elig defin contribut
receiv minimum non-elect contribut concurr payrol period
also permit discretionari contribut labcorp pay
elig employe base servic compani cover substanti
per-cov acquisit employe result covanc acquisit labcorp also
incur expens covanc year end decemb
covanc avail voluntari basi substanti
 covanc employe compani match employe contribut
maximum compani contribut contribut million
bad debt expens million repres lab revenu
y/i
labcorp lengthi list outstand litig
labcorp previous disclos settlement california ex rel hunter
laboratori llc et al quest diagnost incorpor et al lawsuit avoid
uncertainti cost associ prolong litig pursuant execut
second quarter net previous record reserv
paid settlement amount third quarter
compani also agre certain report oblig regard price limit
time period option compani lieu report oblig
provid medi-c discount medi-c otherwis applic maximum
reimburs rate novemb octob
california legislatur enact assembl impos medi-c
payment cut provid includ clinic laboratori cut
current appli rate would otherwis applic
california legislatur enact assembl direct depart
healthcar servic dhc establish new reimburs rate medi-c
clinic laboratori servic base payment made california clinic laboratori
similar servic third-parti payer provid new rate
set process medi-c payment clinic laboratori servic
reduc addit payment reduct impos assembl
percent test date servic juli
cap payment set lowest maximum allow establish
medicar program term hunter lab settlement agreement
enact california legisl termin compani report oblig
oblig provid discount lieu report agreement april
california approv payment reduct assembl
new rate methodolog establish new rate effect juli
new rate enter state comput system februari
rate implement recoup began taken
togeth chang expect materi impact
compani consolid revenu result oper
labcorp respond octob subpoena depart
 human servic offic inspector gener region offic new york
barclay laboratori corp america hldg
august unit state district court southern district new
york unseal fals claim act lawsuit unit state america ex rel npt
associ laboratori corpor america hold alleg
compani offer unitedhealthcar kickback form discount return
medicar busi plaintiff third amend complaint alleg
compani bill practic violat fals claim act state district
columbia lawsuit seek actual trebl damag civil penalti
alleg fals claim well recoveri cost attorney fee legal expens
neither govern state govern interven lawsuit
labcorp motion dismiss grant octob plaintiff grant
right replead januari plaintiff file motion request leav file
amend complaint seal vacat brief schedul compani
motion dismiss govern review amend complaint court
grant motion vacat brief date plaintiff file amend
complaint seal labcorp vigor defend lawsuit
labcorp receiv variou subpoena sinc relat medicaid
bill compani cooper request
may labcorp serv fals claim act lawsuit state georgia
ex rel hunter laboratori llc chri riedel quest diagnost incorpor et
al file state court fulton counti georgia lawsuit file competitor
laboratori alleg compani overcharg georgia medicaid program
state georgia file notic declin august compani
serv complaint case remov unit state district
court northern district georgia lawsuit seek actual trebl damag
civil penalti alleg fals claim well recoveri cost attorney
fee legal expens march labcorp motion dismiss
grant plaintiff repli complaint compani file motion
dismiss first amend complaint may court dismiss plaintiff
anti-kickback claim remand remain state law claim state court
fulton counti juli compani file motion dismiss remain
claim plaintiff file opposit compani motion dismiss
august also state georgia file brief amicu curia labcorp
vigor defend lawsuit
august labcorp serv put class action lawsuit sanduski
well center llc et al medtox scientif inc et al file unit state
district court district minnesota lawsuit alleg
februari defend violat telephon consum protect act
tcpa send unsolicit facsimil plaintiff recipi
without recipi prior express invit permiss lawsuit seek
greater actual damag sum violat subject trebl
tcpa injunct relief septemb plaintiff motion class
certif deni januari labcorp motion summari judgment
remain individu claim grant plaintiff file notic appeal
may unit state court appeal eighth circuit issu
decis order revers district court decis deni class
certif eighth circuit remand matter proceed
decemb district court grant plaintiff renew motion
class certif labcorp vigor defend lawsuit
august labcorp serv put class action lawsuit patti
davi laboratori corpor america et al file circuit court
barclay laboratori corp america hldg
thirteenth judici circuit hillsborough counti florida complaint alleg
compani violat florida consum collect practic act bill patient
collect benefit worker compens statut lawsuit
seek injunct relief actual statutori damag well recoveri
attorney fee legal expens april circuit court grant
compani motion judgment plead plaintiff appeal
circuit court rule florida second district court appeal labcorp
vigor defend lawsuit
decemb labcorp receiv civil investig demand issu pursuant
 fals claim act attorney offic south carolina
request inform regard remuner servic provid compani
physician also receiv draw processing/handl fee competitor
laboratori health diagnost laboratori inc singulex inc compani
cooper request
august compani serv put class action lawsuit
daniel bloomquist covanc inc et al file superior court california
counti san diego complaint alleg compani violat california
labor code california busi profess code fail provid overtim
wage fail provid meal rest period fail pay hour work fail
pay wage owe upon termin fail provid accur item
well recoveri attorney fee cost octob case
remov unit state district court southern district california
labcorp vigor defend lawsuit
individu defend breach
prior compani acquisit sequenom august
august six put class-act lawsuit file behalf purport
sequenom stockhold unit state district court southern district
california challeng acquisit transact complaint assert claim
sequenom member board director nune action also name
compani savoy acquisit corp savoy wholli own subsidiari
compani defend complaint alleg defend violat
section secur exchang act fail
disclos certain allegedli materi inform addit complaint alleg
fiduciari duti sequenom
sharehold action sought among thing injunct relief enjoin
merger august parti enter memorandum understand
above-referenc action connect settlement sequenom
agre make certain addit disclosur stockhold settlement
